Suppr超能文献

一项关于联合抗逆转录病毒药物依从性预测因素的前瞻性研究。

A prospective study of predictors of adherence to combination antiretroviral medication.

作者信息

Golin Carol E, Liu Honghu, Hays Ron D, Miller Loren G, Beck C Keith, Ickovics Jeanette, Kaplan Andrew H, Wenger Neil S

机构信息

Department of Health Behavior and Health Education, University of North Carolina at Chapel Hill, Sheps Center for Health Services Research, Chapel Hill, NC 27599-7590, USA.

出版信息

J Gen Intern Med. 2002 Oct;17(10):756-65. doi: 10.1046/j.1525-1497.2002.11214.x.

Abstract

OBJECTIVE

Adherence to complex antiretroviral therapy (ART) is critical for HIV treatment but difficult to achieve. The development of interventions to improve adherence requires detailed information regarding barriers to adherence. However, short follow-up and inadequate adherence measures have hampered such determinations. We sought to assess predictors of long-term (up to 1 year) adherence to newly initiated combination ART using an accurate, objective adherence measure.

DESIGN

A prospective cohort study of 140 HIV-infected patients at a county hospital HIV clinic during the year following initiation of a new highly active ART regimen.

MEASURES AND MAIN RESULTS

We measured adherence every 4 weeks, computing a composite score from electronic medication bottle caps, pill count and self-report. We evaluated patient demographic, biomedical, and psychosocial characteristics, features of the regimen, and relationship with one's HIV provider as predictors of adherence over 48 weeks. On average, subjects took 71% of prescribed doses with over 95% of patients achieving suboptimal (<95%) adherence. In multivariate analyses, African-American ethnicity, lower income and education, alcohol use, higher dose frequency, and fewer adherence aids (e.g., pillboxes, timers) were independently associated with worse adherence. After adjusting for demographic and clinical factors, those actively using drugs took 59% of doses versus 72% for nonusers, and those drinking alcohol took 66% of doses versus 74% for nondrinkers. Patients with more antiretroviral doses per day adhered less well. Participants using no adherence aids took 68% of doses versus 76% for those in the upper quartile of number of adherence aids used.

CONCLUSIONS

Nearly all patients' adherence levels were suboptimal, demonstrating the critical need for programs to assist patients with medication taking. Interventions that assess and treat substance abuse and incorporate adherence aids may be particularly helpful and warrant further study.

摘要

目的

坚持复杂的抗逆转录病毒疗法(ART)对HIV治疗至关重要,但难以实现。开发改善依从性的干预措施需要有关依从性障碍的详细信息。然而,随访时间短和依从性测量方法不足阻碍了此类判定。我们试图使用准确、客观的依从性测量方法评估新开始联合ART治疗的长期(长达1年)依从性的预测因素。

设计

对一家县医院HIV诊所的140名HIV感染患者在开始新的高效ART方案后的一年内进行前瞻性队列研究。

测量方法和主要结果

我们每4周测量一次依从性,通过电子药瓶盖、药丸计数和自我报告计算综合得分。我们评估了患者的人口统计学、生物医学和心理社会特征、治疗方案的特点以及与HIV治疗提供者的关系,作为48周依从性的预测因素。平均而言,受试者服用了规定剂量的71%,超过95%的患者依从性未达最佳(<95%)。在多变量分析中,非裔美国人种族、低收入和低教育水平、饮酒、更高的服药频率以及更少的依从性辅助工具(如药盒、定时器)与较差的依从性独立相关。在调整了人口统计学和临床因素后,正在吸毒的患者服用了59%的剂量,而非吸毒者为72%;饮酒的患者服用了66%的剂量,而非饮酒者为74%。每天服用更多抗逆转录病毒药物剂量的患者依从性较差。未使用依从性辅助工具的参与者服用了68%的剂量,而使用依从性辅助工具数量处于上四分位数的参与者为76%。

结论

几乎所有患者的依从性水平都未达最佳,这表明迫切需要帮助患者服药的项目。评估和治疗药物滥用并纳入依从性辅助工具的干预措施可能特别有帮助,值得进一步研究。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验